167 related articles for article (PubMed ID: 2940143)
1. In vitro synthesis of antibody to hepatitis B virus antigen by circulating lymphocytes from chronic HBsAg carriers and patients with acute hepatitis B.
Murase K; Kakumu S; Tsubouchi A; Yoshioka K; Sakamoto N
Gastroenterol Jpn; 1986 Apr; 21(2):145-51. PubMed ID: 2940143
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.
Dusheiko GM; Hoofnagle JH; Cooksley WG; James SP; Jones EA
J Clin Invest; 1983 May; 71(5):1104-13. PubMed ID: 6602149
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of antibody production to hepatitis B surface antigen by interleukin 2.
Kakumu S; Fuji A; Tahara H; Yoshioka K; Sakamoto N
J Clin Lab Immunol; 1988 May; 26(1):25-7. PubMed ID: 3263506
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of antibody production to hepatitis B surface antigen by anti-idiotypic antibody.
Kakumu S; Murase K; Tsubouchi A; Yoshioka K; Sakamoto N
Gut; 1986 Sep; 27(9):1069-72. PubMed ID: 3489655
[TBL] [Abstract][Full Text] [Related]
6. Presence and meaning of anti-HBc IgM as determined by ELISA in patients with acute type B hepatitis and healthy HBsAg carriers.
Kryger P; Mathiesen LR; Aldershville J; Nielsen JO
Hepatology; 1981; 1(3):233-7. PubMed ID: 7286902
[TBL] [Abstract][Full Text] [Related]
7. Functional implications of hepatitis B surface antigen (HBsAg) in the T cells of chronic HBV carriers.
Nagaraju K; Naik SR; Naik S
J Viral Hepat; 1997 Jul; 4(4):221-30. PubMed ID: 9278219
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF
Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872
[TBL] [Abstract][Full Text] [Related]
9. [Antinuclear antibody (anti-HBc) and liver pathology in acute and chronic virus B hepatitis].
Dentico P; Pastore G; Buongiorno R; Angarano G; Lapedota E; Schiraldi O
Boll Soc Ital Biol Sper; 1979 Jul; 55(12):1141-6. PubMed ID: 317942
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection.
Böcher WO; Herzog-Hauff S; Herr W; Heermann K; Gerken G; Meyer Zum Büschenfelde KH; Löhr HF
Clin Exp Immunol; 1996 Jul; 105(1):52-8. PubMed ID: 8697635
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus markers in anti-HBc only positive individuals.
Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
[TBL] [Abstract][Full Text] [Related]
12. Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells.
Kurose K; Akbar SM; Yamamoto K; Onji M
Immunology; 1997 Dec; 92(4):494-500. PubMed ID: 9497491
[TBL] [Abstract][Full Text] [Related]
13. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
Perrillo RP; Chau KH; Overby LR; Decker RH
Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
[TBL] [Abstract][Full Text] [Related]
15. In vitro anti-HBs antibody synthesis from anti-hepatitis B vaccine recipients.
Barnaba V; Levrero M; Ruberti G; van Dyke A; Perrone A; Musca A; Balsano F
Clin Exp Immunol; 1987 Nov; 70(2):283-8. PubMed ID: 2962789
[TBL] [Abstract][Full Text] [Related]
16. HBcAg induced T-cell independent anti-HBc production in chronic HBsAg carriers.
Sylvan SP; Hellström UB; Fei G; Norder H; Magnius L; Lindh G
Arch Virol Suppl; 1992; 4():29-35. PubMed ID: 1450704
[TBL] [Abstract][Full Text] [Related]
17. The clinical relevance of the antibody to hepatitis B core antigen (anti-HBc): a review.
Hess G; Arnold W
J Virol Methods; 1980 Dec; 2(1-2):107-17. PubMed ID: 7014579
[TBL] [Abstract][Full Text] [Related]
18. Follow-up of anti-HBc titers in healthy HBsAg carriers and patients with chronic inflammatory liver diseases.
Dormeyer HH; Arnold W; Schönborn H; Hess G; Knolle J; Meyer zum Büschenfelde KH
Digestion; 1981; 22(6):289-93. PubMed ID: 7333415
[TBL] [Abstract][Full Text] [Related]
19. IgM antibody to hepatitis B core antigen (anti-HBc IgM) in "healthy" HBsAg carriers: a longitudinal study of 75 cases.
Dromeyer HH; Arnold W; Kryger P; Nielsen JO; Meyer zum Büschenfelde KH
Klin Wochenschr; 1981 Jun; 59(12):675-8. PubMed ID: 7253541
[TBL] [Abstract][Full Text] [Related]
20. In vitro immune responses to hepatitis B surface antigens S and preS2 during acute infection by hepatitis B virus in humans.
Cupps TR; Hoofnagle JH; Ellis RW; Miller WJ; Gerin JL; Volkman DJ; Haas-Smith SA
J Infect Dis; 1990 Mar; 161(3):412-9. PubMed ID: 2313122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
